PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function
Condition(s):Renal Impairment; Normal Renal FunctionLast Updated:May 15, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Renal Impairment; Normal Renal FunctionLast Updated:May 15, 2023Completed
Condition(s):Renal Impairment; HealthyLast Updated:December 6, 2016Completed
Condition(s):Renal Impaired; Gilteritinib; Normal Renal Function; Pharmacokinetics of ASP2215Last Updated:July 17, 2023Completed
Condition(s):Renal ImpairmentLast Updated:January 8, 2024Completed
Condition(s):Renal ImpairmentLast Updated:February 16, 2023Recruiting
Condition(s):InfectionLast Updated:June 29, 2021Completed
Condition(s):Renal ImpairmentLast Updated:August 14, 2023Active, not recruiting
Condition(s):Alzheimer’s Disease; Huntington’s DiseaseLast Updated:December 30, 2009Completed
Condition(s):Metastatic CancerLast Updated:December 9, 2020Terminated
Condition(s):Renal Insufficiency; Kidney DiseaseLast Updated:August 11, 2016Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.